Robinson v Wentworth Area Health Service

In Robinson v Wentworth Area Health Service, the applicant, Ms Robinson, brought a complaint against the respondent, the Wentworth Area Health Service, alleging indirect discrimination based on disability. The matter was heard in the Anti-Discrimination Tribunal, and the tribunal was tasked with determining whether the respondent’s refusal to provide Ms Robinson with take-home doses of methadone constituted indirect discrimination under the Anti-Discrimination Act 1977. The legal issues before the tribunal included the definition and application of indirect discrimination, the respondent’s obligations under the Act, and whether the respondent’s policy and practice of not providing take-home doses of methadone to patients who could not attend the clinic daily placed Ms Robinson at a disadvantage because of her disabilities.

The tribunal considered whether the respondent’s policy was a requirement that applied to all patients and whether the policy had the effect of disadvantaging Ms Robinson because of her disabilities. The tribunal found that the respondent’s policy of not providing take-home doses of methadone was a requirement that applied to all patients, regardless of their individual circumstances. However, the tribunal also found that the policy had the effect of disadvantaging Ms Robinson because of her disabilities, as it made it impossible for her to attend the clinic daily due to her Hepatitis C and chronic back pain. The tribunal concluded that the respondent had failed to take reasonable steps to accommodate Ms Robinson’s disabilities and that the policy amounted to indirect discrimination.

The tribunal rejected the respondent’s application to dismiss the complaint and ordered Ms Robinson to provide further documents to support her complaint, including medical evidence of the extent of her disabilities, evidence as to why the alternative drugs were not suitable to her situation, and evidence of her financial position to show that she could not afford to pay for pharmacy doses. The tribunal also ordered that the matter be listed for a case conference on 21 February 2005 at 10 a.m.